Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
3.110
-0.070 (-2.20%)
Aug 28, 2026, 4:00 PM EDT - Market closed
Perspective Therapeutics Stock Forecast
Stock Price Forecast
According to 16 analysts polled by S&P Global, Perspective Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $12.53. The average 1-year stock price forecast is 302.89% higher than the current stock price, while the lowest is $5.00 (+60.77%) and the highest is $18 (+478.78%).
Price Target: $12.53 (+302.89%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Perspective Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 12 | 12 | 12 | 12 | 13 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 15 | 15 | 15 | 15 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst BMO Capital No rating | BMO Capital | Buy Initiates $11 | Buy | Initiates | $11 | +253.70% | Aug 18, 2026 |
| JonesTrading | JonesTrading | Buy Reiterates $18 | Buy | Reiterates | $18 | +478.78% | Aug 14, 2026 |
| Bank of America Securities | Bank of America Securities | Hold Reiterates $6 → $5 | Hold | Reiterates | $6 → $5 | +60.77% | Aug 14, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $15 | Buy | Maintains | $15 | +382.32% | Aug 11, 2026 |
Unknown Analyst Wedbush No rating | Wedbush | Buy Maintains $11 | Buy | Maintains | $11 | +253.70% | Aug 11, 2026 |
Financial Forecast
Revenue This Year
325.78K
from 884.00K
Decreased by -63.15%
Revenue Next Year
365.71K
from 325.78K
Increased by 12.26%
EPS This Year
-0.99
from -1.40
EPS Next Year
-1.02
from -0.99
EPS and Forward PE are based on non-GAAP adjusted numbers.